Literature DB >> 14934141

[Buscopan].

H WICK.   

Abstract

Entities:  

Keywords:  GANGLIA, AUTONOMIC/effect of drugs on; SCOPOLAMINE/derivatives

Mesh：

Substances：

Year:  1951        PMID： 14934141

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol


× No keyword cloud information.
  9 in total

1.  Protection against anaphylactic shock by various substances.

Authors:  H HERXHEIMER
Journal:  Br J Pharmacol Chemother       Date:  1955-06

2.  [Role of acetylcholine, atropine and ganglion-blocking agents in excitation transmission of vagal stimulation on the intestines].

Authors:  H WICK
Journal:  Acta Neuroveg (Wien)       Date:  1957

3.  [Effect of ganglion-blocking agents on serum iron].

Authors:  A POPP; E CZERMAK
Journal:  Acta Neuroveg (Wien)       Date:  1956

4.  [Pharmacological study on synthetic alkoxy-tropine derivatives].

Authors:  E ROTHLIN; M TAESCHLER; H KONZETT; A CERLETTI
Journal:  Experientia       Date:  1954-03-15

5.  [Effect of synaptotropic substances on certain efferent and afferent structures of the autonomic nervous system].

Authors:  H KONZETT; E ROTHLIN
Journal:  Experientia       Date:  1953-11-15

6.  [Studies on the effect of anticholinergic and ganglion-blocking quaternary ammonium compounds on diseases of the gastroduodenal tract].

Authors:  H BROICHER
Journal:  Klin Wochenschr       Date:  1953-10-01

7.  [Roentgenological observations on the effects of new inhibitory drugs on stomach and gallbladder motility].

Authors:  H REINECKE
Journal:  Klin Wochenschr       Date:  1953-05-15

8.  Dose-response relationships of intravenous hyoscine butylbromide and atropine sulphate on heart rate in healthy volunteers.

Authors:  S L Grainger; S E Smith
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

9.  Centrally acting anticholinergic drug trihexyphenidyl is highly effective in reducing nightmares associated with post-traumatic stress disorder.

Authors:  Katsumasa Sogo; Masanobu Sogo; Yoshie Okawa
Journal:  Brain Behav       Date:  2021-05-14       Impact factor: 2.708
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.